BIOTECH: Key embryonic stem cell patent rejected
A key patent on how to grow human embryonic stem cells has been rejected by a federal agency, the latest twist in a complicated, years-long case. Researchers in San Diego’s large biotech community say the decision could make it easier to turn …
[Read the full article here]Related News:
WARF loses a round in stem cell patent dispute
USPTO rejects WARF’s stem cell patent claims
Novocell Obtains U.S. Patent For Drug Screening Human Embryonic Cell Derived-Endoderm Cells